Successful treatment of visceral leishmaniasis with fluconazole and allopurinol in a patient with renal failure

被引：4
作者：
Colakoglu, M
Yaylali, GF
Colakoglu, NY
Yilmaz, M
机构：
[1] Pamukkale Univ, Sch Med, Dept Nephrol, Denizli, Turkey
[2] Pamukkale Univ, Sch Med, Dept Pathol, Denizli, Turkey
[3] Pamukkale Univ, Sch Med, Dept Gastroenterol, Denizli, Turkey
来源：
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES | 2006年 / 38卷 / 03期
关键词：
D O I：
10.1080/00365540500321405
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Standard treatments for visceral leishmaniasis ( antimonials, amphotericin B and pentamidine) pose several problems. Failure of antimonials or severe toxicity is particularly troublesome in patients with renal insufficiency. We report a case of visceral leishmaniaisis and renal insufficiency successfully treated with fluconazole and allopurinol for 4 months.
引用
收藏
页码：208 / 210
页数：4
相关论文
共 50 条
  • [31] METRONIDAZOLE TREATMENT IN A PATIENT WITH AIDS AND VISCERAL LEISHMANIASIS
    ARRANZCASO, JA
    ALBARRANHERNANDEZ, F
    CUADRADOGOMEZ, LM
    GONZALEZPALACIOS, R
    AIDS, 1995, 9 (12) : 1377 - 1378
  • [32] Acute renal failure as initial presentation of visceral leishmaniasis in an HIV-1-infected patient
    Clevenbergh, P
    Okome, MN
    Benoit, S
    Bendini, JC
    De Salvador, F
    Elbeze, M
    Cassuto, E
    Marty, P
    Dellamonica, P
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2002, 34 (07) : 546 - 547
  • [33] Miltefosine in the treatment of a case of visceral leishmaniasis with renal dysfunction
    Kumar, N.
    Pandey, K.
    Das, V. N. R.
    Sinha, P. K.
    Topno, R. K.
    Verma, N.
    Lal, C. S.
    Das, P.
    Bhattacharya, S. K.
    ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2007, 101 (07): : 649 - 651
  • [34] TREATMENT OF VISCERAL LEISHMANIASIS UNRESPONSIVE TO SODIUM STIBOGLUCONATE (ANTIMONY USING A COMBINATION OF ANTIMONY AND ALLOPURINOL)
    CHUNGE, CN
    GACHIHI, GS
    CHULAY, JD
    MUIGAI, R
    WERE, B
    ANABWANI, G
    RASHID, JR
    WASUNNA, K
    BRYCESON, ADM
    EAST AFRICAN MEDICAL JOURNAL, 1984, 61 (12) : 938 - 938
  • [35] Miltefosine Rescue Treatment for Visceral Leishmaniasis Relapse Patient
    Bastola, Anup
    Shrestha, Mitesh
    Chalise, Bimal Sharma
    Mishra, Abhdesh Kumar
    Devkota, Lina
    CASE REPORTS IN INFECTIOUS DISEASES, 2019, 2019
  • [36] Treatment of resistant visceral leishmaniasis with interferon gamma in combination with liposomal amphotericin B and allopurinol
    Khodabandeh, Mahmoud
    Rostami, Ali
    Borhani, Katayoun
    Gamble, H. Ray
    Mohammadi, Mohsen
    PARASITOLOGY INTERNATIONAL, 2019, 72
  • [37] TREATMENT OF CUTANEOUS LEISHMANIASIS WITH ALLOPURINOL
    BARZILAI, A
    FRIEDMAN, J
    TRAU, H
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 32 (03) : 518 - 518
  • [38] ASSESSMENT OF ALLOPURINOL PLUS MEGLUMINE ANTIMONIATE IN THE TREATMENT OF VISCERAL LEISHMANIASIS IN PATIENTS INFECTED WITH HIV
    LAGUNA, F
    LOPEZVELEZ, R
    SORIANO, V
    MONTILLA, P
    ALVAR, J
    GONZALEZLAHOZ, JM
    JOURNAL OF INFECTION, 1994, 28 (03) : 255 - 259
  • [39] Azathioprine/prednisone/tacrolimusCutaneous leishmaniasis treated with allopurinol and fluconazole: case report
    Reactions Weekly, 2013, 1454 (1) : 11 - 11
  • [40] Comparative study of the use of miltefosine, miltefosine plus allopurinol, and allopurinol in dogs with visceral leishmaniasis
    de Lima Ruy Dias, Alvaro Felipe
    Boa Sorte Ayres, Eveline da Cruz
    de Oliveira Martins, Domingos Tabajara
    Maruyama, Fernanda Harumi
    de Oliveira, Ruberlei Godinho
    de Carvalho, Matheus Roberto
    Parto Ferreira de Almeida, Arleana do Bom
    de Souza Teixeira, Anna Louisa
    Mendonca, Adriane Jorge
    Franco Sousa, Valeria Regia
    EXPERIMENTAL PARASITOLOGY, 2020, 217
12345